0

(+)-N-3-Benzylnirvanol

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATAP790676403
CAS790676-40-3
Structure
MDL NumberMFCD09840024
Molecular Weight294.35
InChI KeyZMZDHUHMXXALFX-SFHVURJKSA-N
Description≥98% (HPLC), powder
SolubilityDMSO: >20 mg/mL; H2O: insoluble
Assay≥98% (HPLC)
Formpowder
Size5MG, 10MG
Storage Conditions2-8°C
1

Active-site Characteristics of CYP2C19 and CYP2C9 Probed With Hydantoin and Barbiturate Inhibitors

Hisashi Suzuki, M Byron Kneller, Dan A Rock, Jeffrey P Jones, William F Trager, Allan E Rettie

Arch Biochem Biophys. 2004 Sep 1;429(1):1-15.

PMID: 15288804

1

Impact of Cytochrome P450 Variation on Meperidine

Jessica L Murray, Susan L Mercer, Klarissa D Jackson

Xenobiotica. 2020 Feb;50(2):209-222.

PMID: 30902024

1

Investigation of the Inhibition of Eight Major Human Cytochrome P450 Isozymes by a Probe Substrate Cocktail

Guru R Valicherla, Amrut Mishra, Srinivas Lenkalapelly, Bhupathi Jillela, Femi M Francis, Lakshman Rajagopalan, Pratima Srivastava

Xenobiotica. 2019 Dec;49(12):1396-1402.

PMID: 30747554

1

Relative Roles of CYP2C19 and CYP3A4/5 in Midazolam 1'-hydroxylation

C Emoto, K Iwasaki

Xenobiotica. 2007 Jun;37(6):592-603.

PMID: 17614006

1

Verification of the Selectivity of (+)N-3-benzylnirvanol as a CYP2C19 Inhibitor

Robert L Walsky, R Scott Obach

Drug Metab Dispos. 2003 Mar;31(3):343.

PMID: 12625332

  • Verification code
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Online Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

  • Tel:
  • Email:

Follow us on

qrcode